Dutch based company Acatris, recently formed through the merger of food and health companies Daminco, Orffa Health & Nutrition, Schouten USA and SoyLife Nederland, has recently published research claiming that SoyLife is a complex nutritional ingredient 'beyond just soy protein and isoflavones.' The conclusion follows research, sponsored by Acatris, that looked at the possible prebiotic and saponin effects of SoyLife.
Acatris reports this week that when SoyLife was added to an in vitro model of the human digestive system, it was found that there was an increase in the presence of the healthy bacteria Lactobacillussp., and that this increase resulted in substantial metabolism of soy isoflavones suggesting, the company claims, that this is due to the prebiotic effect of SoyLife.
Bile acids, left unchecked, can damage the cells in the intestinal wall of the digestive system and destroy healthy bacteria. A separate in vitro study suggests that SoyLife was able to reduce the amount of damage to the intestinal wall by bile acid simulators and that Lactobacillus sp. was able to survive in spite of the bile acids. It is possible that the saponin portion of SoyLife may protect the gut and its healthy bacteria by reducing the negative impact of bile salts.
Acatris is a subsidiary of the Dutch company, the Royal Schouten Group.